Corneal Biomechanical Analysis Using Brillouin Microscopy
1 other identifier
observational
220
1 country
1
Brief Summary
The objective of this study is to measure the Brillouin biomechanical properties in keratoconic corneas and characterize biomechanical alterations that occur after corneal procedures that inherently strengthen or weaken the cornea by evaluating the change in Brillouin metrics before and after treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
February 17, 2026
September 1, 2025
5.1 years
May 19, 2020
February 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Brillouin Metrics
Brillouin metrics to be evaluated include localized Mean Brillouin modulus measure across the cornea and at each depth of the corneal stroma
Difference between baseline and 3 months after intervention
Study Arms (6)
1: Normal Controls
Patients with normal corneas without any prior surgery to serve as the control group
2 Keratoconus
Patients with various stages of keratoconus
3: LASIK
Patients with normal corneas who are undergoing laser in situ keratomileusis (LASIK)
Group 4: PRK
Patients with normal corneas who are undergoing photorefractive keratectomy (PRK)
5: SMILE
Patients with normal corneas who are undergoing small incision lenticular extraction (SMILE)
6: CXL
Patients with keratoconus who are undergoing corneal cross-linking (CXL)
Interventions
The Brillouin clinical instrument is comprised of three parts: a human interface, a laser-scanning confocal microscope, and an etalon-based spectrometer. The human interface is a modified ophthalmic slit-lamp instrument with chin support and headrest. The light source is a single longitudinal mode CW laser at 780 nm. A polarizing beam splitter and quarter-wave plate assembly sends the laser beam to the human interface. To focus light into the eye, a long-working distance microscope objective is used. Brillouin scattered light from the eye is collected with a single-mode optical fiber. For spectral analysis, a two-stage VIPA-etalon spectrometer configured with the cross-axis cascade principle and the spectrum is measured on a EM-CCD camera.
Eligibility Criteria
Group 1: Patients with normal corneas Group 2: Patients with keratoconus Group 3: Patients with normal corneas undergoing LASIK Group 4: Patients with normal corneas undergoing PRK Group 5: Patients with normal corneas undergoing SMILE Group 6: Patients with keratoconus undergoing CXL
You may qualify if:
- patients aged 18-60 with keratoconus
- patients aged 18-60 with normal corneas,
- patients aged 18-60 undergoing refractive surgery (LASIK, PRK, SMILE)
- patients aged 18-60 with keratoconus undergoing CXL
You may not qualify if:
- outside age range
- history of previous ocular surgeries
- unable to cooperate for the Brillouin microscopic examination
- unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Cleveland Cliniclead
- University of Marylandcollaborator
Study Sites (1)
Cleveland Clinic Cole Eye Institute
Cleveland, Ohio, 44195, United States
Related Publications (7)
Zhang H, Roozbahani M, Piccinini AL, Golan O, Hafezi F, Scarcelli G, Randleman JB. Depth-Dependent Reduction of Biomechanical Efficacy of Contact Lens-Assisted Corneal Cross-linking Analyzed by Brillouin Microscopy. J Refract Surg. 2019 Nov 1;35(11):721-728. doi: 10.3928/1081597X-20191004-01.
PMID: 31710374BACKGROUNDWebb JN, Langille E, Hafezi F, Randleman JB, Scarcelli G. Biomechanical Impact of Localized Corneal Cross-linking Beyond the Irradiated Treatment Area. J Refract Surg. 2019 Apr 1;35(4):253-260. doi: 10.3928/1081597X-20190304-01.
PMID: 30984983BACKGROUNDRandleman JB, Su JP, Scarcelli G. Biomechanical Changes After LASIK Flap Creation Combined With Rapid Cross-Linking Measured With Brillouin Microscopy. J Refract Surg. 2017 Jun 1;33(6):408-414. doi: 10.3928/1081597X-20170421-01.
PMID: 28586502BACKGROUNDScarcelli G, Pineda R, Yun SH. Brillouin optical microscopy for corneal biomechanics. Invest Ophthalmol Vis Sci. 2012 Jan 20;53(1):185-90. doi: 10.1167/iovs.11-8281.
PMID: 22159012RESULTScarcelli G, Kling S, Quijano E, Pineda R, Marcos S, Yun SH. Brillouin microscopy of collagen crosslinking: noncontact depth-dependent analysis of corneal elastic modulus. Invest Ophthalmol Vis Sci. 2013 Feb 19;54(2):1418-25. doi: 10.1167/iovs.12-11387.
PMID: 23361513RESULTScarcelli G, Besner S, Pineda R, Yun SH. Biomechanical characterization of keratoconus corneas ex vivo with Brillouin microscopy. Invest Ophthalmol Vis Sci. 2014 Jun 17;55(7):4490-5. doi: 10.1167/iovs.14-14450.
PMID: 24938517RESULTScarcelli G, Besner S, Pineda R, Kalout P, Yun SH. In vivo biomechanical mapping of normal and keratoconus corneas. JAMA Ophthalmol. 2015 Apr;133(4):480-2. doi: 10.1001/jamaophthalmol.2014.5641. No abstract available.
PMID: 25611213RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff Physician
Study Record Dates
First Submitted
May 19, 2020
First Posted
October 22, 2020
Study Start
June 1, 2021
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
February 17, 2026
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
there is no plan to share data